Pam R. Taub, MD, FACC - Making the Case for Novel LDL-C–Lowering Therapies in the Management of Pediatric and Adult Homozygous Familial Hypercholesterolemia

CME in Minutes: Education in Primary Care

EpisodeOct 9, 202316m

Pam R. Taub, MD, FACC - Making the Case for Novel LDL-C–Lowering Therapies in the Management of Pediatric and Adult Homozygous Familial Hypercholesterolemia

CME in Minutes: Education in Primary Care

EpisodeOct 9, 202316m

Please visit answersincme.com/TJX860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in cardiology discusses low-density lipoprotein (LDL) receptor–independent therapies for homozygous familial hypercholesterolemia (HoFH) via two patient case studies. Upon completion of this activity, participants should be better able to: Identify patients with HoFH through differential diagnosis; Review the clinical profiles of novel strategies to reduce LDL cholesterol in patients with HoFH that work independently of LDL receptors; and Outline patient-centered strategies to maximize quality of life for patients with HoFH on lipid-lowering therapies.

Top comments

Get answers in 25 minutes or less from world-class experts and earn CME/CE credit with CME in Minutes: Education in Primary Care by Answers in CME. Benefit from digests of latest advancements, thoughtful case studies, and nuanced perspectives anytime, anywhere, and on any device. Inspiring and engaging programs designed for the busy primary care providers to cover the diagnosis, treatment, follow-up, and clinical management of various disease states. Earning your CME/CE credit has never been faster or easier. Visit the URL for each individual program to request continuing education credit or access the slides.

answersincme.com

Switch to the Fountain App

Open in Fountain